DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Erythrocin Stearate (Erythromycin Stearate) - Drug Interactions, Contraindications, Overdosage, etc

 
 



DRUG INTERACTIONS

ERYTHROCIN STEARATE drug label information in our database does not contain a dedicated section on drug interactions. Please check subsections of WARNINGS AND PRECAUTIONS as well as other sources.

OVERDOSAGE

In case of overdosage, erythromycin should be discontinued. Overdosage should be handled with the prompt elimination of unabsorbed drug and all other appropriate measures should be instituted.

Erythromycin is not removed by peritoneal dialysis or hemodialysis.

CONTRAINDICATIONS

Erythromycin is contraindicated in patients with known hypersensitivity to this antibiotic.

Erythromycin is contraindicated in patients taking terfenadine, astemizole, pimozide or cisapride. (See PRECAUTIONS - Drug Interactions.)

REFERENCES

  1. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Third Edition. Approved Standard NCCLS Document M7-A3, Vol. 13, No. 25 NCCLS, Villanova , PA, December 1993.
  2. National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobial Disk Susceptibility Tests, Fifth Edition. Approved Standard NCCLS Document M2-A5, Vol. 13, No. 24 NCCLS, Villanova , PA, December 1993.
  3. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association: Prevention of Rheumatic Fever. Circulation. 78(4):1082-1086, October 1988.
  4. Honein, M.A., et. al.: Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. The Lancet 1999;354 (9196):2101-5.
  5. Data on file, Abbott Laboratories.

FILMTAB-Film-sealed tablets, Abbott.

Abbott Laboratories

North Chicago, IL 60064, U.S.A.

Revision Date: 06/07/2006

ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE)
PRODUCT INFO
Product Code 0074-6346 Dosage Form TABLET, FILM COATED
Route Of Administration ORAL DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
erythromycin stearate (erythromycin) Active 250 MILLIGRAM In 1 TABLET
Cellulosic polymers Inactive
corn starch Inactive
D&C Red No. 7 Inactive
polacrilin potassium Inactive
polyethylene glycol Inactive
povidone Inactive
propylene glycol Inactive
sodium carboxymethylcellulose Inactive
sodium citrate Inactive
sorbic acid Inactive
sorbitan monooleate Inactive
titanium dioxide Inactive
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color PINK Score 1
Shape ROUND Symbol true
Imprint Code ES Coating true
Size 13mm
PACKAGING
# NDC Package Description Multilevel Packaging
1 0074-6346-20 100 TABLET In 1 BOTTLE None
2 0074-6346-53 500 TABLET In 1 BOTTLE None
3 0074-6346-19 500 TABLET In 1 BOTTLE None
4 0074-6346-38 10 BLISTER PACK In 1 BOX, UNIT-DOSE contains a BLISTER PACK
4 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-6346-38)

ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE)
PRODUCT INFO
Product Code 0074-6316 Dosage Form TABLET, FILM COATED
Route Of Administration ORAL DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
erythromycin stearate (erythromycin) Active 500 MILLIGRAM In 1 TABLET
Cellulosic polymers Inactive
cornstarch Inactive
FD&C Red No. 3 Inactive
magnesium hydroxide Inactive
polacrilin potassium Inactive
povidone Inactive
propylene glycol Inactive
sorbitan monooleate Inactive
titanium dioxide Inactive
vanillin Inactive
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color PINK Score 1
Shape OVAL Symbol true
Imprint Code ET Coating true
Size 19mm
PACKAGING
# NDC Package Description Multilevel Packaging
1 0074-6316-13 100 TABLET In 1 BOTTLE None

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017